N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials
Aim. To analyze the currently available published randomized controlled clinical trials to evaluate the effect of N-acetylcysteine on the incidence of contrast-induced acute kidney injury (CI-AKI).Material and methods. The meta-analysis was performed in accordance with the PRISMA guidelines based on...
Saved in:
Main Authors: | E. M. Mezhonov (Author), Yu. A. Vyalkina (Author), S. V. Shalaev (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Administration of N-acetylcysteine for contrast-induced acute kidney injury; an updated mini-review
by: Sam Mirfendereski, et al.
Published: (2024) -
Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
by: Sara K. Richter, et al.
Published: (2015) -
The standard dose versus double dose of N-acetylcysteine to prevent contrast-induced nephropathy; a randomized controlled clinical trial
by: Rahimeh Eskandarian, et al.
Published: (2018) -
Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury
by: Zhang J, et al.
Published: (2018) -
Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis
by: Liu L, et al.
Published: (2018)